Crestor Study Will Boost Statin Demand

12/11/08 06:27 aVascular Pathology
AstraZeneca's statin was found to cut cardiovascular risk in those with normal cholesterol by 45%. But are the potentially huge extra costs worth it? ... Full story

Tags: Vascular Technology